Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Activin type II receptor signaling in cardiac aging and heart failure.

Roh JD, Hobson R, Chaudhari V, Quintero P, Yeri A, Benson M, Xiao C, Zlotoff D, Bezzerides V, Houstis N, Platt C, Damilano F, Lindman BR, Elmariah S, Biersmith M, Lee SJ, Seidman CE, Seidman JG, Gerszten RE, Lach-Trifilieff E, Glass DJ, Rosenzweig A.

Sci Transl Med. 2019 Mar 6;11(482). pii: eaau8680. doi: 10.1126/scitranslmed.aau8680.

PMID:
30842316
2.

Pulmonary Artery Mass in a Patient With Tuberculous Pericarditis.

Churchill JL, Ard KL, Roh JD, Lu MT.

CASE (Phila). 2019 Jan 2;3(1):2-5. doi: 10.1016/j.case.2018.11.004. eCollection 2019 Feb. No abstract available.

3.

Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice.

Jung H, Park H, Choi Y, Kang H, Lee E, Kweon H, Roh JD, Ellegood J, Choi W, Kang J, Rhim I, Choi SY, Bae M, Kim SG, Lee J, Chung C, Yoo T, Park H, Kim Y, Ha S, Um SM, Mo S, Kwon Y, Mah W, Bae YC, Kim H, Lerch JP, Paik SB, Kim E.

Nat Neurosci. 2018 Sep;21(9):1218-1228. doi: 10.1038/s41593-018-0208-z. Epub 2018 Aug 13.

PMID:
30104731
4.

NGL-2 Deletion Leads to Autistic-like Behaviors Responsive to NMDAR Modulation.

Um SM, Ha S, Lee H, Kim J, Kim K, Shin W, Cho YS, Roh JD, Kang J, Yoo T, Noh YW, Choi Y, Bae YC, Kim E.

Cell Rep. 2018 Jun 26;23(13):3839-3851. doi: 10.1016/j.celrep.2018.05.087.

5.

Lrfn2-Mutant Mice Display Suppressed Synaptic Plasticity and Inhibitory Synapse Development and Abnormal Social Communication and Startle Response.

Li Y, Kim R, Cho YS, Song WS, Kim D, Kim K, Roh JD, Chung C, Park H, Yang E, Kim SJ, Ko J, Kim H, Kim MH, Bae YC, Kim E.

J Neurosci. 2018 Jun 27;38(26):5872-5887. doi: 10.1523/JNEUROSCI.3321-17.2018. Epub 2018 May 24.

6.

Cardiac macrophages promote diastolic dysfunction.

Hulsmans M, Sager HB, Roh JD, Valero-Muñoz M, Houstis NE, Iwamoto Y, Sun Y, Wilson RM, Wojtkiewicz G, Tricot B, Osborne MT, Hung J, Vinegoni C, Naxerova K, Sosnovik DE, Zile MR, Bradshaw AD, Liao R, Tawakol A, Weissleder R, Rosenzweig A, Swirski FK, Sam F, Nahrendorf M.

J Exp Med. 2018 Feb 5;215(2):423-440. doi: 10.1084/jem.20171274. Epub 2018 Jan 16.

7.

IRF3 and type I interferons fuel a fatal response to myocardial infarction.

King KR, Aguirre AD, Ye YX, Sun Y, Roh JD, Ng RP Jr, Kohler RH, Arlauckas SP, Iwamoto Y, Savol A, Sadreyev RI, Kelly M, Fitzgibbons TP, Fitzgerald KA, Mitchison T, Libby P, Nahrendorf M, Weissleder R.

Nat Med. 2017 Dec;23(12):1481-1487. doi: 10.1038/nm.4428. Epub 2017 Nov 6.

8.

Increased Excitatory Synaptic Transmission of Dentate Granule Neurons in Mice Lacking PSD-95-Interacting Adhesion Molecule Neph2/Kirrel3 during the Early Postnatal Period.

Roh JD, Choi SY, Cho YS, Choi TY, Park JS, Cutforth T, Chung W, Park H, Lee D, Kim MH, Lee Y, Mo S, Rhee JS, Kim H, Ko J, Choi SY, Bae YC, Shen K, Kim E, Han K.

Front Mol Neurosci. 2017 Mar 22;10:81. doi: 10.3389/fnmol.2017.00081. eCollection 2017.

9.

SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion.

Lie E, Ko JS, Choi SY, Roh JD, Cho YS, Noh R, Kim D, Li Y, Kang H, Choi TY, Nam J, Mah W, Lee D, Lee SG, Kim HM, Kim H, Choi SY, Um JW, Kang MG, Bae YC, Ko J, Kim E.

Nat Commun. 2016 Aug 2;7:12328. doi: 10.1038/ncomms12328.

10.

Synaptic adhesion molecule IgSF11 regulates synaptic transmission and plasticity.

Jang S, Oh D, Lee Y, Hosy E, Shin H, van Riesen C, Whitcomb D, Warburton JM, Jo J, Kim D, Kim SG, Um SM, Kwon SK, Kim MH, Roh JD, Woo J, Jun H, Lee D, Mah W, Kim H, Kaang BK, Cho K, Rhee JS, Choquet D, Kim E.

Nat Neurosci. 2016 Jan;19(1):84-93. doi: 10.1038/nn.4176. Epub 2015 Nov 23.

11.

Splicing-Dependent Trans-synaptic SALM3-LAR-RPTP Interactions Regulate Excitatory Synapse Development and Locomotion.

Li Y, Zhang P, Choi TY, Park SK, Park H, Lee EJ, Lee D, Roh JD, Mah W, Kim R, Kim Y, Kwon H, Bae YC, Choi SY, Craig AM, Kim E.

Cell Rep. 2015 Sep 8;12(10):1618-30. doi: 10.1016/j.celrep.2015.08.002. Epub 2015 Aug 28.

12.

Clinical review of the effects of hominis placental pharmacopuncture in the treatment of facial spasm patients.

Jo NY, Kim JH, Roh JD.

J Pharmacopuncture. 2013 Sep;16(3):52-7. doi: 10.3831/KPI.2013.16.019.

13.

Adverse myocardial effects of B-vitamin therapy in subjects with chronic kidney disease and hyperhomocysteinaemia.

Rafeq Z, Roh JD, Guarino P, Kaufman J, Joseph J.

Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):836-42. doi: 10.1016/j.numecd.2012.07.002. Epub 2012 Aug 16.

PMID:
22902185
14.

Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel.

Hibino N, Villalona G, Pietris N, Duncan DR, Schoffner A, Roh JD, Yi T, Dobrucki LW, Mejias D, Sawh-Martinez R, Harrington JK, Sinusas A, Krause DS, Kyriakides T, Saltzman WM, Pober JS, Shin'oka T, Breuer CK.

FASEB J. 2011 Aug;25(8):2731-9. doi: 10.1096/fj.11-182246. Epub 2011 May 12.

15.

Cardiac presentation of anaplastic large-cell lymphoma.

Punnoose LR, Roh JD, Hu S, Udell JA, Wagle N, Kirshenbaum JM, Lacasce AS.

J Clin Oncol. 2010 Jul 1;28(19):e314-6. doi: 10.1200/JCO.2009.26.7583. Epub 2010 Jun 1. No abstract available.

PMID:
20516445
16.

Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.

Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK.

Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4669-74. doi: 10.1073/pnas.0911465107. Epub 2010 Mar 5.

17.

Tissue-engineered arterial grafts: long-term results after implantation in a small animal model.

Mirensky TL, Nelson GN, Brennan MP, Roh JD, Hibino N, Yi T, Shinoka T, Breuer CK.

J Pediatr Surg. 2009 Jun;44(6):1127-32; discussion 1132-3. doi: 10.1016/j.jpedsurg.2009.02.035.

PMID:
19524728
18.

Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Brennan MP, Dardik A, Hibino N, Roh JD, Nelson GN, Papademitris X, Shinoka T, Breuer CK.

Ann Surg. 2008 Sep;248(3):370-7. doi: 10.1097/SLA.0b013e318184dcbd.

19.

Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo.

Nelson GN, Roh JD, Mirensky TL, Wang Y, Yi T, Tellides G, Pober JS, Shkarin P, Shapiro EM, Saltzman WM, Papademetris X, Fahmy TM, Breuer CK.

FASEB J. 2008 Nov;22(11):3888-95. doi: 10.1096/fj.08-107367. Epub 2008 Aug 18.

20.

Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings.

Nelson GN, Mirensky T, Brennan MP, Roh JD, Yi T, Wang Y, Breuer CK.

Arch Surg. 2008 May;143(5):488-94. doi: 10.1001/archsurg.143.5.488.

21.

Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlett TF, Tellides G, Sinusas AJ, Pober JS, Saltzman WM, Kyriakides TR, Breuer CK.

Biomaterials. 2008 Apr;29(10):1454-63. doi: 10.1016/j.biomaterials.2007.11.041. Epub 2007 Dec 27.

22.

Centrifugal seeding increases seeding efficiency and cellular distribution of bone marrow stromal cells in porous biodegradable scaffolds.

Roh JD, Nelson GN, Udelsman BV, Brennan MP, Lockhart B, Fong PM, Lopez-Soler RI, Saltzman WM, Breuer CK.

Tissue Eng. 2007 Nov;13(11):2743-9.

PMID:
17880269
23.

Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.

Roh JD, Brennan MP, Lopez-Soler RI, Fong PM, Goyal A, Dardik A, Breuer CK.

J Pediatr Surg. 2007 Jan;42(1):198-202.

PMID:
17208565

Supplemental Content

Support Center